Loading…
Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria
Various criteria have been proposed to classify the inflammatory myositides (IIMs) polymyositis (PM) and dermatomyositis (DM). However, none have received universal acceptance. Our aim was to assess the performance of the main criteria used to classify IIM. Specialist consultant diagnosis was consid...
Saved in:
Published in: | Clinical and experimental rheumatology 2013-09, Vol.31 (5), p.767-769 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 769 |
container_issue | 5 |
container_start_page | 767 |
container_title | Clinical and experimental rheumatology |
container_volume | 31 |
creator | Linklater, Helen Pipitone, Nicolò Rose, Michael R Norwood, Fiona Campbell, Richard Salvarani, Carlo Scott, D L Gordon, Patrick |
description | Various criteria have been proposed to classify the inflammatory myositides (IIMs) polymyositis (PM) and dermatomyositis (DM). However, none have received universal acceptance. Our aim was to assess the performance of the main criteria used to classify IIM. Specialist consultant diagnosis was considered the gold standard.
Patients attending King's College Hospital (KCH) or Reggio Emilia Hospital (REH) since 1990 with a diagnosis of IIM or non-inflammatory myopathy were identified, and their records and laboratory investigations retrospectively reviewed. Where the complete data required for the classification criteria or a final physician diagnosis was unavailable, patients were excluded. 52 patients with a specialist diagnosis of PM, DM, inclusion body myositis (IBM) or non-inflammatory myopathy were included. Agreement between specialist consultant diagnosis and classification criteria was measured using Cohen's kappa (κ) statistics. Sensitivity and specificity were also calculated.
The Dalakas (2003) criteria demonstrated substantial agreement with specialist diagnosis: κ=0.69, sensitivity 77%, specificity 99%. The European Neuromuscular Centre criteria (ENMC) demonstrated fair agreement: κ=0.49, sensitivity 71%, specificity 82%. Other criteria performed less well. In particular, the Bohan and Peter criteria demonstrated a specificity of only 29%.
The criteria of Dalakas (2003) agreed best with specialist consultant diagnosis. The criteria of Bohan and Peter demonstrated very poor specificity. Prospective studies are required to develop improved classification criteria. |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1434747503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1434747503</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-6f920b135a452be5a560192cce0bd374079fede29a11502363b21e69a9319da13</originalsourceid><addsrcrecordid>eNo1kM1KAzEYRWeh2Fp9BcnSzUD-p3EnxT8ouFFwN3yT-WIjk8mYpNB5ey3V1YVzD3dxz6olFYbXa6U_FtVlzl-Ucq10c1EtuFhTvZZyWXWbAXL2bvbjJ_G9jxOUnbfEj26AEKDENJMwnzDmO2JjmCAd7bJDMmFyMQUYLZLoSPYHggefy7G3yRdMHq6qcwdDxuu_XFXvjw9vm-d6-_r0srnf1hNnrNTaGU47JhRIxTtUoDRlhluLtOtFI2ljHPbIDTCmKBdadJyhNmAEMz0wsapuT7tTit97zKUNPlscBhgx7nPLpJCNbBQVv-rNn7rvAvbtlHyANLf_v4gfM-Nfag</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1434747503</pqid></control><display><type>article</type><title>Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria</title><source>Freely Accessible Journals</source><creator>Linklater, Helen ; Pipitone, Nicolò ; Rose, Michael R ; Norwood, Fiona ; Campbell, Richard ; Salvarani, Carlo ; Scott, D L ; Gordon, Patrick</creator><creatorcontrib>Linklater, Helen ; Pipitone, Nicolò ; Rose, Michael R ; Norwood, Fiona ; Campbell, Richard ; Salvarani, Carlo ; Scott, D L ; Gordon, Patrick</creatorcontrib><description>Various criteria have been proposed to classify the inflammatory myositides (IIMs) polymyositis (PM) and dermatomyositis (DM). However, none have received universal acceptance. Our aim was to assess the performance of the main criteria used to classify IIM. Specialist consultant diagnosis was considered the gold standard.
Patients attending King's College Hospital (KCH) or Reggio Emilia Hospital (REH) since 1990 with a diagnosis of IIM or non-inflammatory myopathy were identified, and their records and laboratory investigations retrospectively reviewed. Where the complete data required for the classification criteria or a final physician diagnosis was unavailable, patients were excluded. 52 patients with a specialist diagnosis of PM, DM, inclusion body myositis (IBM) or non-inflammatory myopathy were included. Agreement between specialist consultant diagnosis and classification criteria was measured using Cohen's kappa (κ) statistics. Sensitivity and specificity were also calculated.
The Dalakas (2003) criteria demonstrated substantial agreement with specialist diagnosis: κ=0.69, sensitivity 77%, specificity 99%. The European Neuromuscular Centre criteria (ENMC) demonstrated fair agreement: κ=0.49, sensitivity 71%, specificity 82%. Other criteria performed less well. In particular, the Bohan and Peter criteria demonstrated a specificity of only 29%.
The criteria of Dalakas (2003) agreed best with specialist consultant diagnosis. The criteria of Bohan and Peter demonstrated very poor specificity. Prospective studies are required to develop improved classification criteria.</description><identifier>ISSN: 0392-856X</identifier><identifier>PMID: 23806844</identifier><language>eng</language><publisher>Italy</publisher><subject>Biomarkers - blood ; Biopsy ; Dermatomyositis - blood ; Dermatomyositis - classification ; Dermatomyositis - diagnosis ; Electromyography ; Female ; Health Status Indicators ; Humans ; Italy ; London ; Male ; Middle Aged ; Physical Examination ; Polymyositis - blood ; Polymyositis - classification ; Polymyositis - diagnosis ; Predictive Value of Tests ; Referral and Consultation ; Retrospective Studies ; Severity of Illness Index</subject><ispartof>Clinical and experimental rheumatology, 2013-09, Vol.31 (5), p.767-769</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23806844$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Linklater, Helen</creatorcontrib><creatorcontrib>Pipitone, Nicolò</creatorcontrib><creatorcontrib>Rose, Michael R</creatorcontrib><creatorcontrib>Norwood, Fiona</creatorcontrib><creatorcontrib>Campbell, Richard</creatorcontrib><creatorcontrib>Salvarani, Carlo</creatorcontrib><creatorcontrib>Scott, D L</creatorcontrib><creatorcontrib>Gordon, Patrick</creatorcontrib><title>Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria</title><title>Clinical and experimental rheumatology</title><addtitle>Clin Exp Rheumatol</addtitle><description>Various criteria have been proposed to classify the inflammatory myositides (IIMs) polymyositis (PM) and dermatomyositis (DM). However, none have received universal acceptance. Our aim was to assess the performance of the main criteria used to classify IIM. Specialist consultant diagnosis was considered the gold standard.
Patients attending King's College Hospital (KCH) or Reggio Emilia Hospital (REH) since 1990 with a diagnosis of IIM or non-inflammatory myopathy were identified, and their records and laboratory investigations retrospectively reviewed. Where the complete data required for the classification criteria or a final physician diagnosis was unavailable, patients were excluded. 52 patients with a specialist diagnosis of PM, DM, inclusion body myositis (IBM) or non-inflammatory myopathy were included. Agreement between specialist consultant diagnosis and classification criteria was measured using Cohen's kappa (κ) statistics. Sensitivity and specificity were also calculated.
The Dalakas (2003) criteria demonstrated substantial agreement with specialist diagnosis: κ=0.69, sensitivity 77%, specificity 99%. The European Neuromuscular Centre criteria (ENMC) demonstrated fair agreement: κ=0.49, sensitivity 71%, specificity 82%. Other criteria performed less well. In particular, the Bohan and Peter criteria demonstrated a specificity of only 29%.
The criteria of Dalakas (2003) agreed best with specialist consultant diagnosis. The criteria of Bohan and Peter demonstrated very poor specificity. Prospective studies are required to develop improved classification criteria.</description><subject>Biomarkers - blood</subject><subject>Biopsy</subject><subject>Dermatomyositis - blood</subject><subject>Dermatomyositis - classification</subject><subject>Dermatomyositis - diagnosis</subject><subject>Electromyography</subject><subject>Female</subject><subject>Health Status Indicators</subject><subject>Humans</subject><subject>Italy</subject><subject>London</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Physical Examination</subject><subject>Polymyositis - blood</subject><subject>Polymyositis - classification</subject><subject>Polymyositis - diagnosis</subject><subject>Predictive Value of Tests</subject><subject>Referral and Consultation</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><issn>0392-856X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNo1kM1KAzEYRWeh2Fp9BcnSzUD-p3EnxT8ouFFwN3yT-WIjk8mYpNB5ey3V1YVzD3dxz6olFYbXa6U_FtVlzl-Ucq10c1EtuFhTvZZyWXWbAXL2bvbjJ_G9jxOUnbfEj26AEKDENJMwnzDmO2JjmCAd7bJDMmFyMQUYLZLoSPYHggefy7G3yRdMHq6qcwdDxuu_XFXvjw9vm-d6-_r0srnf1hNnrNTaGU47JhRIxTtUoDRlhluLtOtFI2ljHPbIDTCmKBdadJyhNmAEMz0wsapuT7tTit97zKUNPlscBhgx7nPLpJCNbBQVv-rNn7rvAvbtlHyANLf_v4gfM-Nfag</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Linklater, Helen</creator><creator>Pipitone, Nicolò</creator><creator>Rose, Michael R</creator><creator>Norwood, Fiona</creator><creator>Campbell, Richard</creator><creator>Salvarani, Carlo</creator><creator>Scott, D L</creator><creator>Gordon, Patrick</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20130901</creationdate><title>Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria</title><author>Linklater, Helen ; Pipitone, Nicolò ; Rose, Michael R ; Norwood, Fiona ; Campbell, Richard ; Salvarani, Carlo ; Scott, D L ; Gordon, Patrick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-6f920b135a452be5a560192cce0bd374079fede29a11502363b21e69a9319da13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biomarkers - blood</topic><topic>Biopsy</topic><topic>Dermatomyositis - blood</topic><topic>Dermatomyositis - classification</topic><topic>Dermatomyositis - diagnosis</topic><topic>Electromyography</topic><topic>Female</topic><topic>Health Status Indicators</topic><topic>Humans</topic><topic>Italy</topic><topic>London</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Physical Examination</topic><topic>Polymyositis - blood</topic><topic>Polymyositis - classification</topic><topic>Polymyositis - diagnosis</topic><topic>Predictive Value of Tests</topic><topic>Referral and Consultation</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Linklater, Helen</creatorcontrib><creatorcontrib>Pipitone, Nicolò</creatorcontrib><creatorcontrib>Rose, Michael R</creatorcontrib><creatorcontrib>Norwood, Fiona</creatorcontrib><creatorcontrib>Campbell, Richard</creatorcontrib><creatorcontrib>Salvarani, Carlo</creatorcontrib><creatorcontrib>Scott, D L</creatorcontrib><creatorcontrib>Gordon, Patrick</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Linklater, Helen</au><au>Pipitone, Nicolò</au><au>Rose, Michael R</au><au>Norwood, Fiona</au><au>Campbell, Richard</au><au>Salvarani, Carlo</au><au>Scott, D L</au><au>Gordon, Patrick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria</atitle><jtitle>Clinical and experimental rheumatology</jtitle><addtitle>Clin Exp Rheumatol</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>31</volume><issue>5</issue><spage>767</spage><epage>769</epage><pages>767-769</pages><issn>0392-856X</issn><abstract>Various criteria have been proposed to classify the inflammatory myositides (IIMs) polymyositis (PM) and dermatomyositis (DM). However, none have received universal acceptance. Our aim was to assess the performance of the main criteria used to classify IIM. Specialist consultant diagnosis was considered the gold standard.
Patients attending King's College Hospital (KCH) or Reggio Emilia Hospital (REH) since 1990 with a diagnosis of IIM or non-inflammatory myopathy were identified, and their records and laboratory investigations retrospectively reviewed. Where the complete data required for the classification criteria or a final physician diagnosis was unavailable, patients were excluded. 52 patients with a specialist diagnosis of PM, DM, inclusion body myositis (IBM) or non-inflammatory myopathy were included. Agreement between specialist consultant diagnosis and classification criteria was measured using Cohen's kappa (κ) statistics. Sensitivity and specificity were also calculated.
The Dalakas (2003) criteria demonstrated substantial agreement with specialist diagnosis: κ=0.69, sensitivity 77%, specificity 99%. The European Neuromuscular Centre criteria (ENMC) demonstrated fair agreement: κ=0.49, sensitivity 71%, specificity 82%. Other criteria performed less well. In particular, the Bohan and Peter criteria demonstrated a specificity of only 29%.
The criteria of Dalakas (2003) agreed best with specialist consultant diagnosis. The criteria of Bohan and Peter demonstrated very poor specificity. Prospective studies are required to develop improved classification criteria.</abstract><cop>Italy</cop><pmid>23806844</pmid><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0392-856X |
ispartof | Clinical and experimental rheumatology, 2013-09, Vol.31 (5), p.767-769 |
issn | 0392-856X |
language | eng |
recordid | cdi_proquest_miscellaneous_1434747503 |
source | Freely Accessible Journals |
subjects | Biomarkers - blood Biopsy Dermatomyositis - blood Dermatomyositis - classification Dermatomyositis - diagnosis Electromyography Female Health Status Indicators Humans Italy London Male Middle Aged Physical Examination Polymyositis - blood Polymyositis - classification Polymyositis - diagnosis Predictive Value of Tests Referral and Consultation Retrospective Studies Severity of Illness Index |
title | Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A01%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Classifying%20idiopathic%20inflammatory%20myopathies:%20comparing%20the%20performance%20of%20six%20existing%20criteria&rft.jtitle=Clinical%20and%20experimental%20rheumatology&rft.au=Linklater,%20Helen&rft.date=2013-09-01&rft.volume=31&rft.issue=5&rft.spage=767&rft.epage=769&rft.pages=767-769&rft.issn=0392-856X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1434747503%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p211t-6f920b135a452be5a560192cce0bd374079fede29a11502363b21e69a9319da13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1434747503&rft_id=info:pmid/23806844&rfr_iscdi=true |